ContraFect Corporation (CFRX:NASDAQ) jumped higher at $0.12, representing a gain of 31.2%. On Tue, Jan 24, 2023, CFRX:NASDAQ hit a New 2-Week High of $0.12. From Tue, Jan 10, 2023, the stock recorded 22.22% Up Days and 10.00% Green Days
The stock spiked on Wed, Nov 30, 2022 at $0.2 with a volume of 10M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- bioAffinity Technologies Inc. (BIAF:NASDAQ), 74.38%
- Grom Social Enterprises Inc. (GROM:NASDAQ), 44.14%
- Axcella Health Inc. (AXLA:NASDAQ), 38.31%
- Baudax Bio, Inc. (BXRX:NASDAQ), 32.38%
- ContraFect Corporation (CFRX:NASDAQ), 31.24%
- Sotherly Hotels Inc. (SOHO:NASDAQ), 23.4%
- Bit Brother Limited (BTB:NASDAQ), 23.08%
- IronNet Inc. (IRNT:NYSE), 22.58%
- PyroGenesis (PYR:NASDAQ), 22.34%
- Vincerx Pharma Inc. (VINC:NASDAQ), 22.22%